Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
13 April 2025
| N 14:22 | Ubrogepant diffhist +5,022 Omid Afkhami-Ardakani talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Ubrogepant |aOrAn=a |drugClass=Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist |indicationType=treatment |indication=migraine with or without aura in adults. |adverseReactions=Somnolence, Nausea, Dry mouth, Hypersensitivity reactions including rash, urticaria, and facial edema. |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color...") | ||||
| N 13:35 | Lemborexant diffhist +5,310 Omid Afkhami-Ardakani talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Lemborexant |aOrAn=a |drugClass=Dual Orexin Receptor Antagonist (DORA) |indicationType=treatment |indication=adult patients with insomnia |adverseReactions=Somnolence, Fatigue, Headache, Abnormal dreams, Sleep paralysis, and Hypnagogic hallucinations. |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition...") | ||||